Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Merck & Co. describes new thrombin inhibitors

Jan. 14, 1998

Audit of Genzyme Transgenics' rhATIII production facility triggers milestone

Jan. 13, 1998

Roberts seeks to broaden market for Agrylin

Jan. 13, 1998

Cell adhesion inhibitors from Merck KGaA

Jan. 12, 1998

Thrombin inhibitors reported by BMS

Jan. 9, 1998

Vasoflux preclinical data presented at major hematology congress

Jan. 8, 1998

Efficacy of recombinant hirudin demonstrated in patients with DIC

Jan. 8, 1998

Antiplatelet effects of policosanol, aspirin and policosanol + aspirin in humans

Jan. 5, 1998

New anticoagulants reported by Berlex

Jan. 2, 1998

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026